insights_auto
Why is INO down 3,97%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,45 US$
arrow_downward
-3,97%(-0,060) 1D
1,29 US$
arrow_downward
-11,03% (-0,16)todayPre-market
Closed: 10 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,48 US$
High
1,51 US$
Low
1,40 US$
Mkt. cap
244,95 მლნ.
Avg. vol.
18,40 მლნ.
Volume
9,06 ათ.
52-wk high
2,72 US$
52-wk low
0,57 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
103,40 მლნ.
No. of employees
112
Open
1,48 US$
High
1,51 US$
Low
1,40 US$
Mkt. cap
244,95 მლნ.
Avg. vol.
18,40 მლნ.
Volume
9,06 ათ.
52-wk high
2,72 US$
52-wk low
0,57 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
103,40 მლნ.
No. of employees
112
News stories
From web sources and news partners
TradingView
·
1 საათის წინ
Key facts: INO Extends Runway; 2027 Launch; Data, Partner Search
GuruFocus
·
5 საათის წინ
FMR LLC Adds Inovio Pharmaceuticals Inc (INO) Shares -- Stock Looks 625% Overvalued on GF Value
Yahoo Finance
·
7 საათის წინ
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Investing.com Canada
·
9 საათის წინ
Inovio Q3 2026 slides: VOCERYQ approval amid wider loss By Investing.com
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc